Exozymes Inc.
Biotechnology company · Monrovia, California, United States · Nasdaq: EXOZ
Exozymes Inc. is a biotechnology company headquartered in Monrovia, California, United States. Its shares trade on Nasdaq under the ticker EXOZ. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $2.7 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $11,718 sold in a notice filed in 2024.
Exozymes at a glance
What does Exozymes do?
US government research funding
4 SBIR/STTR small-business research awards from US health agencies, $2.7 million in total (2020 to 2025). NIH funding came from the National Center for Complementary and Integrative Health, National Institute of General Medical Sciences.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $11,718 sold (2024).
Frequently asked questions about Exozymes
Where is Exozymes headquartered?
Exozymes Inc. is headquartered in Monrovia, California, United States.
What does Exozymes do?
Exozymes Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Exozymes a public company?
Yes. Exozymes Inc. trades on Nasdaq under the ticker EXOZ.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.